Buscar
Mostrando ítems 1-9 de 9
Triple GLP-1/GIP/glucagon receptor agonists, a potential novel treatment strategy in Alzheimer’s disease (2020)
(Taylor and Francis Ltd, 2019)
The preclinical discovery and development of opicapone for the treatment of Parkinson’s disease (2020)
(Taylor and Francis Ltd, 2020)